Suresh S Ramalingam MD

Contact Information:

Phone: 404-778-5378

Email: ssramal@emory.edu

View Emory directory entry

School/Division:

Professor

EVP Health Affairs

Exec.V.P. for Health Affairs

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 108

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. ...

Article

Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors

by Anthony J. Olszanski; David C. Smith; Luis H. Camacho; John Thompson; Suresh S Ramalingam; R Donald Harvey; Luis Campos; David Ferry; Shande Tang; Ling Gao; Howard Safran

2016

Article

Common cancer-driver mutations and their association with abnormally methylated genes in lung adenocarcinoma from never-smokers

by Mathewos Tessema; Michael Rossi; Maria A. Picchi; Christin M. Yingling; Yong Lin; Suresh Ramalingam; Steven A. Belinsky

2018

Article

Clinical prognostic model for older patients with advanced non-small cell lung cancer

by Suresh Ramalingam; Jeffrey Bradley; AK Ganti; X Wang; TE Stinchcombe; Y Wang; HJ Cohen; K Kelly; R Paulus; EE Vokes; H Pang

2019

Article

Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients

by Huali Wu; Ramesh K. Ramanathan; Beth A. Zamboni; Sandra Strychor; Suresh Ramalingam; Robert P. Edwards; David M. Friedland; Ronald G. Stoller; Chandra P. Belani; Lauren J. Maruca; Yung-Jue Bang; William C. Zamboni

2012

Article

The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2)

by Dara L. Aisner; Lynette M. Sholl; Lynne D, Berry; Michael Rossi; Heidi Chen; Junya Fujimoto; Andre L. Moreira; Suresh Ramalingam; Liza C. Villaruz; Gregory A. Otterson; Eric Haura; Katerina Politi; Bonnie Glisson; Jeremy Cetnar; Edward B. Garon; Joan Schiller; Saiama N. Waqar; Lecia V, Sequist; Julie Brahmer; Yu Shyr; Kelly Kugler; Ignacio I. Wistuba; Bruce E. Johnson; John D. Minna; Mark G. Kris; Paul A. Bunn; David J. Kwiatkowski

2018

Article

Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset

by Yuichiro Ohe; Fumio Imamura; Naoyuki Nogami; Isamu Okamoto; Takayasu Kurata; Terufumi Kato; Shunichi Sugawara; Suresh Ramalingam; Hirohiko Uchida; Rachel Hodge; Sarah L. Vowler; Andrew Walding; Kazuhiko Nakagawa

2018